InvestorsHub Logo
Followers 118
Posts 20248
Boards Moderated 0
Alias Born 06/13/2011

Re: None

Tuesday, 02/20/2024 5:51:28 PM

Tuesday, February 20, 2024 5:51:28 PM

Post# of 254
RZ402 is the near term catalyst . P2 data on DME ...with 3 doses 50mg, 200 mg and 400mg .
The 50mg and and 200 mg dose were shown similar to placebo in safety profile. Believe this is the first time using 400 mg dose .
Trial is fully enrolled with 94 patients
12 wk trial followed by 4 wk follow up
Data mid / late Q2 2024.
High risk spec , some talented people in the Co
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RZLT News